Epitopea closes their $31 million pre-Series A financing.

We are thrilled to share a major milestone for Epitopea with the closing of their $31 million pre-Series A financing, bringing Epitopea’s total capital raised to over $45 million USD.

This achievement underscores the growing momentum and innovation in the RNA therapy space.

Congratulations to the entire Epitopea team on this significant accomplishment!

To read the press release: Epitopea Closes USD $31 million Pre-Series A Financing – Epitopea